EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 25-Jun-2026 19:16 ET (25-Jun-2026 23:16 GMT/UTC)

9-Feb-2026

Mayo Clinic study finds chemotherapy before surgery improves survival in early-stage pancreatic cancer

A Mayo Clinic study is providing new insights into how treatment sequence can affect survival in patients with early-stage pancreatic cancer, suggesting that many patients may benefit from receiving chemotherapy before surgery.

Journal: Journal of the National Comprehensive Cancer Network

9-Feb-2026

Let’s get on pancreatic cancer’s nerves

Cold Spring Harbor Laboratory
Peer-Reviewed Publication

Cold Spring Harbor Laboratory postdoc Jeremy Nigri and colleagues in the Tuveson lab have discovered that the nervous system plays an active role in pancreatic cancer development—even before tumor formation. Disrupting interactions between nerves and fibroblasts could lead to new treatments or make standard procedures like chemo and immunotherapy more effective.

Journal: Cancer Discovery
Funder: Defense Health Agency, Thompson Foundation, Pershing Square Foundation, Simons Foundation, Cold Spring Harbor Laboratory, Northwell Health, U.S. Department of Defense, Pancreatic Cancer Action Network, Donaldson Foundation

9-Feb-2026

Simple blood test may help identify colorectal cancer patients at higher risk for recurrence and death

H. Lee Moffitt Cancer Center & Research Institute
Peer-Reviewed Publication

A new study led by researchers at Moffitt Cancer Center found that blood-based DNA markers known as protein epiScores can help predict which colorectal cancer patients face a higher risk of cancer recurrence or death. Results of the study were published in Clinical Epigenetics.

Researchers identified four protein epiScores that were strongly associated with worse outcomes, with patients showing higher levels experiencing a 60% to 70% greater risk of recurrence. One marker, LGALS3BP, was also linked to overall survival, with higher scores associated with an 80% increased risk of death during follow-up.

Journal: Clinical Epigenetics

9-Feb-2026

New study in JNCCN unlocks important information about how to treat recurring prostate cancer

National Comprehensive Cancer Network
Peer-Reviewed Publication

According to new research in JNCCN, information from prostate-specific membrane antigen (PSMA) PET/CT scans may be able to predict progression-free survival (PFS) and guide treatment planning in patients with rising prostate-specific antigen (PSA) levels following removal of the prostate.

Journal: Journal of the National Comprehensive Cancer Network

9-Feb-2026

New method boosts control and separation of tiny particles – a promising tool for medical research

University of Oulu, Finland
Peer-Reviewed Publication

In nanoscale particle research, precise control and separation have long been a bottleneck in biotechnology. Researchers at the University of Oulu have now developed a new method that improves particle separation and purification. The promising technique could be applied, for example, in cancer research.

Journal: Analytical Chemistry

9-Feb-2026

Have associations between historical redlining and breast cancer survival changed over time?

Wiley
Peer-Reviewed Publication

Historical redlining, a 1930s–1960s residential segregation policy, has been linked to shorter survival time in people with breast cancer. New research published by Wiley online in CANCER reveals that this association has changed over time, with disparities narrowing until recently.

Journal: Cancer

8-Feb-2026

Discovery of new lymph node architecture reshapes understanding of lymphatic physiology

Tohoku University
Peer-Reviewed Publication

Researchers at Tohoku University discovered an intranodal lympho-venous shunt (a sort of bypass route) that could help us unravel the complicated, intertwined network of our body’s lymphatic system.

Journal: The Journal of Pathology

6-Feb-2026

DHL-11, a novel prieurianin-type limonoid isolated from Munronia henryi, targeting IMPDH2 to inhibit triple-negative breast cancer

Compuscript Ltd
Peer-Reviewed Publication

https://doi.org/10.1016/j.apsb.2025.10.031

This new article publication from Acta Pharmaceutica Sinica B, discusses DHL-11, a novel prieurianin-type limonoid isolated from Munronia henryi, targeting IMPDH2 to inhibit triple-negative breast cancer.

6-Feb-2026

Deep learning-based discovery of tetrahydrocarbazoles as broad-spectrum antitumor agents and click-activated strategy for targeted cancer therapy

Compuscript Ltd
Peer-Reviewed Publication

https://doi.org/10.1016/j.apsb.2025.10.005

This new article publication from Acta Pharmaceutica Sinica B, discusses the deep learning-based discovery of tetrahydrocarbazoles as broad-spectrum antitumor agents and click-activated strategy for targeted cancer therapy.

6-Feb-2026

Scientists now know why ovarian cancer spreads so rapidly in the abdomen

Nagoya University
Peer-Reviewed Publication

Ovarian cancer kills more women than any other gynecological cancer. Most patients receive their diagnosis only after the disease spreads throughout the abdomen. Until now, scientists have never fully understood why this cancer advances so fast. A new study led by Nagoya University explains why. Published in Science Advances, the study shows that cancer cells recruit help from protective mesothelial cells that normally line the abdominal cavity. Mesothelial cells lead the invasion and cancer cells follow the pathways they create. These hybrid cell clusters resist chemotherapy better than cancer alone.

Journal: Science Advances